- Home
- NVO vs TMUS Comparison
NVO vs TMUS Comparison
Compare NVO & TMUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- TMUS
- Stock Information
- Founded
- NVO 1923
- TMUS 1994
- Country
- NVO Denmark
- TMUS United States
- Employees
- NVO N/A
- TMUS N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- TMUS Telecommunications Equipment
- Sector
- NVO Health Care
- TMUS Telecommunications
- Exchange
- NVO Nasdaq
- TMUS Nasdaq
- Market Cap
- NVO 243.4B
- TMUS 236.3B
- IPO Year
- NVO N/A
- TMUS N/A
- Fundamental
- Price
- NVO $48.84
- TMUS $206.66
- Analyst Decision
- NVO Buy
- TMUS Buy
- Analyst Count
- NVO 9
- TMUS 16
- Target Price
- NVO $54.33
- TMUS $265.87
- AVG Volume (30 Days)
- NVO 24.1M
- TMUS 5.4M
- Earning Date
- NVO 11-05-2025
- TMUS 10-23-2025
- Dividend Yield
- NVO 2.53%
- TMUS 1.97%
- EPS Growth
- NVO 10.06
- TMUS 18.54
- EPS
- NVO 3.67
- TMUS 10.38
- Revenue
- NVO $49,580,393,058.00
- TMUS $85,847,000,000.00
- Revenue This Year
- NVO $9.21
- TMUS $10.53
- Revenue Next Year
- NVO $5.64
- TMUS $7.34
- P/E Ratio
- NVO $13.29
- TMUS $19.91
- Revenue Growth
- NVO 16.64
- TMUS 7.30
- 52 Week Low
- NVO $43.08
- TMUS $199.41
- 52 Week High
- NVO $112.52
- TMUS $276.49
- Technical
- Relative Strength Index (RSI)
- NVO 47.14
- TMUS 37.20
- Support Level
- NVO $43.08
- TMUS $205.52
- Resistance Level
- NVO $49.53
- TMUS $209.80
- Average True Range (ATR)
- NVO 1.37
- TMUS 3.92
- MACD
- NVO 0.24
- TMUS 0.37
- Stochastic Oscillator
- NVO 77.01
- TMUS 31.19
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 85 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers with its wireless network. It also serves nearly 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.